Abstract

Computer-aided drug design is one of important application areas of intelligent systems. Recently a novel method has been proposed for inverse QSAR/QSPR using both artificial neural networks (ANN) and mixed integer linear programming (MILP), where inverse QSAR/QSPR is a major approach for drug design. This method consists of two phases: In the first phase, a feature function f is defined so that each chemical compound G is converted into a vector f(G) of several descriptors of G, and a prediction function \(\psi \) is constructed with an ANN so that \(\psi (f(G))\) takes a value nearly equal to a given chemical property \(\pi \) for many chemical compounds G in a data set. In the second phase, given a target value \(y^*\) of the chemical property \(\pi \), a chemical structure \(G^*\) is inferred in the following way. An MILP \(\mathcal {M}\) is formulated so that \(\mathcal {M}\) admits a feasible solution \((x^*,y^*)\) if and only if there exist vectors \(x^*\), \(y^*\) and a chemical compound \(G^*\) such that \(\psi (x^*)=y^*\) and \(f(G^*)=x^*\). The method has been implemented for inferring acyclic chemical compounds. In this paper, we propose a new MILP for inferring acyclic chemical compounds by introducing a novel concept, skeleton tree, and conducted computational experiments. The results suggest that the proposed method outperforms the existing method when the diameter of graphs is up to around 6 to 8. For an instance for inferring acyclic chemical compounds with 38 non-hydrogen atoms from C, O and S and diameter 6, our method was \(5\times 10^4\) times faster.

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.